Periodic Reporting for period 1 - PACT4EYE (Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancer)

Ruthenium-based photoactivated chemotherapy (PACT) is a new technology where the toxicity and anticancer activity of a chemotherapy drug is tuned down by attaching a molecular “cage” to the chemotherapy molecule. By doing so, the active but toxic chemotherapy drug is...